Intuitive Surgical (NASDAQ:ISRG) EVP Mark Brosius Sells 46 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 46 shares of the company’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $361.23, for a total transaction of $16,616.58. Following the transaction, the executive vice president directly owned 835 shares of the company’s stock, valued at $301,627.05. This represents a 5.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $350.20, for a total transaction of $8,054.60.
• On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.57, for a total value of $28,918.89.
• On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $394.26, for a total value of $30,358.02.
• On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.67, for a total value of $30,081.59.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $351.00, for a total value of $9,828.00.
• On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $360.21, for a total transaction of $10,085.88.
• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total transaction of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $414.13, for a total transaction of $10,353.25.

Intuitive Surgical Trading Up 0.9%

NASDAQ ISRG opened at $353.24 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a market capitalization of $124.79 billion, a price-to-earnings ratio of 40.46, a PEG ratio of 2.64 and a beta of 1.47. The stock’s 50 day moving average is $378.72 and its two-hundred day moving average is $425.22.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.Intuitive Surgical’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.81 EPS. On average, analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A large meta-analysis found that da Vinci robotic-assisted surgery was associated with statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The findings support the clinical value of Intuitive’s platform and could help drive hospital adoption. New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery
• Positive Sentiment: BTIG reaffirmed its “buy” rating and assigned a $469 price target, implying substantial upside from recent trading levels. Other analyst commentary also remains broadly favorable, although investors may be discounting some recommendations because sell-side ratings tend to be optimistic. BTIG reaffirms buy rating on Intuitive Surgical
• Positive Sentiment: Articles note that ISRG is trading at its cheapest valuation in roughly a decade. Combined with recent revenue growth of about 18% and strong earnings execution, the lower valuation is attracting interest from value-oriented investors. ISRG stock trading at its cheapest in 10 years
• Neutral Sentiment: Intuitive presented at the Wells Fargo Healthcare Conference, keeping investor attention on procedure trends, guidance, competition, and the company’s long-term robotic-surgery opportunity. Intuitive Surgical Wells Fargo Healthcare Conference transcript
• Negative Sentiment: Recent selling pressure has been linked to slower U.S. procedure growth, rising costs, competitive threats, and potential effects from GLP-1 drugs. Investors are also questioning whether the company’s earnings multiple is justified while growth moderates. Why Intuitive Surgical fell more than the broader market
• Negative Sentiment: EVP Mark Brosius reported two sales totaling 69 shares. The transactions were made under a pre-arranged Rule 10b5-1 plan and are small relative to his remaining holdings, limiting their significance; however, broader insider activity has consisted predominantly of sales rather than purchases.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in ISRG. Motiv8 Investments LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $34,000. Main Street Group LTD bought a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $39,000. Vermillion Wealth Management Inc. increased its holdings in shares of Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares in the last quarter. Finally, High Note Wealth LLC increased its holdings in shares of Intuitive Surgical by 50.0% in the fourth quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 23 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ISRG. Evercore set a $430.00 target price on shares of Intuitive Surgical in a research note on Monday, July 6th. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, August 15th. Truist Financial reduced their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research report on Thursday, July 16th. Citigroup decreased their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Finally, KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Twenty-two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $508.68.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.